bf/NASDAQ:ADMP_icon.jpeg

NASDAQ:ADMP

Adamis Pharmaceuticals Corporation

  • Stock

USD

Last Close

0.77

07/09 19:59

Market Cap

7.25M

Beta: 1.23

Volume Today

119.48K

Avg: 1.54M

PE Ratio

−0.12

PFCF: −0.54

Mar '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
net income
-8.16M
-
-13.57M
66.41%
-19.44M
43.22%
-25.54M
31.39%
-39.01M
52.73%
-29.31M
24.87%
-49.39M
68.53%
-45.83M
7.21%
-26.48M
42.22%
depreciation and amortization
296.12K
-
990.29K
234.42%
2.53M
155.95%
3.06M
20.87%
3.10M
1.15%
2.94M
4.98%
3.61M
22.50%
1.44M
60.20%
1.48M
3.33%
deferred income tax
-4.82M
-
-4.59M
-
-343.55K
92.51%
-372.47K
8.42%
1.21M
424.01%
14.49M
1,100.89%
9.21M
36.44%
stock based compensation
596.09K
-
2.51M
321.24%
4.76M
89.50%
6.06M
27.32%
6.54M
7.88%
5.87M
10.22%
4.42M
24.67%
1.98M
55.14%
-340.27K
117.16%
change in working capital
-2.12M
-
13.60K
100.64%
-3.05M
22,551.31%
487.98K
115.99%
-6.54M
1,441.04%
-616.42K
90.58%
5.13M
931.60%
-10.80M
310.66%
-1.34M
87.58%
accounts receivables
-363K
-
-87.63K
75.86%
-421.01K
380.45%
-745.15K
76.99%
737.93K
199.03%
-573.34K
177.70%
-238.49K
58.40%
inventory
1.89K
-
-882.49K
46,767.95%
-4.98M
464.34%
24.76K
100.50%
-3.42M
13,892.08%
-236.15K
93.09%
-820.17K
247.30%
accounts payables
-1.76M
-
-289.22K
83.58%
-1.71M
490.19%
587.15K
134.40%
846.12K
44.11%
574.51K
32.10%
-726.71K
226.49%
1.91M
362.64%
3.93M
106.12%
other working capital
-358.92K
-
302.81K
184.37%
-984.65K
425.16%
870.95K
188.45%
-1.99M
328.35%
-470.54K
76.34%
8.53M
1,912.85%
-11.90M
239.48%
-4.22M
64.56%
other non cash items
7.42M
-
-278.43K
103.75%
-2.75M
888.53%
1.14M
141.43%
3.63M
218.45%
18.46K
99.49%
843.67K
4,470.25%
6.21M
636.31%
775.36K
87.52%
net cash provided by operating activities
-6.78M
-
-10.34M
52.44%
-21.16M
104.73%
-15.13M
28.49%
-32.66M
115.81%
-19.89M
39.11%
-20.90M
5.11%
-37.79M
80.78%
-25.90M
31.45%
investments in property plant and equipment
-10M
-
-121.10K
-
-2.09M
1,625.03%
-3.54M
69.23%
-2.87M
18.92%
-946.21K
66.99%
-1.22M
29.30%
-680.42K
44.39%
acquisitions net
381.88K
-
purchases of investments
sales maturities of investments
other investing activites
-32
-
-24.74K
77,203.13%
1.51M
-
4.16M
176.48%
net cash used for investing activites
-10M
-
260.75K
-
-2.09M
900.76%
-3.54M
69.32%
-2.87M
18.92%
-946.21K
66.99%
282.74K
129.88%
3.48M
1,132.21%
debt repayment
-6.94M
-
-324.65K
-
-2.33M
617.95%
-487.90K
79.07%
-496.79K
1.82%
-90.62K
81.76%
-17.03K
-
common stock issued
25.45M
-
10.57M
58.49%
10.22M
3.31%
16.02M
56.83%
37.62M
134.81%
12.79M
66.01%
18.23M
42.54%
51.75M
183.90%
300K
99.42%
common stock repurchased
dividends paid
other financing activites
3.66M
-
75.59K
97.94%
12.02M
15,806.02%
16.77M
39.45%
1.75M
-
2.19M
24.56%
2.03K
99.91%
net cash used provided by financing activities
22.18M
-
10.64M
52.03%
21.91M
105.93%
30.46M
38.98%
37.13M
21.91%
12.29M
66.90%
19.89M
61.84%
53.94M
171.14%
285K
99.47%
effect of forex changes on cash
68.56K
-
-7.76K
111.32%
net change in cash
5.40M
-
305.98K
94.34%
1.02M
231.75%
13.24M
1,203.99%
938.94K
92.91%
-10.46M
1,214.13%
-1.96M
81.31%
16.50M
943.96%
-22.14M
234.16%
cash at beginning of period
3.77M
-
4.08M
8.11%
5.10M
24.88%
18.33M
259.76%
19.27M
5.12%
8.81M
54.28%
6.75M
23.40%
23.25M
244.51%
cash at end of period
5.40M
-
4.08M
24.48%
5.10M
24.88%
18.33M
259.76%
19.27M
5.12%
8.81M
54.28%
6.86M
22.19%
23.25M
239.16%
1.11M
95.22%
operating cash flow
-6.78M
-
-10.34M
52.44%
-21.16M
104.73%
-15.13M
28.49%
-32.66M
115.81%
-19.89M
39.11%
-20.90M
5.11%
-37.79M
80.78%
-25.90M
31.45%
capital expenditure
-10M
-
-121.10K
-
-2.09M
1,625.03%
-3.54M
69.23%
-2.87M
18.92%
-946.21K
66.99%
-1.22M
29.30%
-680.42K
44.39%
free cash flow
-16.78M
-
-10.34M
38.41%
-21.28M
105.90%
-17.22M
19.08%
-36.19M
110.16%
-22.75M
37.14%
-21.85M
3.98%
-39.01M
78.55%
-26.58M
31.86%

All numbers in USD (except ratios and percentages)